Doktorand in der Arbeitsgruppe Prof. Dr. Robert Bittl (TP B01)
Institut für Experimentalphysik
Fachbereich Physik
Freie Universität Berlin

Kontakt:
siavash.saeidpour (at) fu-berlin.de

Dissertationsthema:
EPR spectroscopic investigations on drug delivery and release of nanocarriers into cutaneous cells and excised skin.

Erstbetreuer: Prof. Dr. R. Bittl

Publikationen:

Giulbudagian M, Hönzke S, Bergueiro J, Isik D, Schumacher F, Saeidpour S, Lohan SB, Meinke MC, Teutloff C, Schäfer-Korting M, Yealland G, Kleuser B, Hedtrich S, Calderón M 2017. Enhanced topical delivery of dexamethasone by β-cyclodextrin decorated thermoresponsive nanogels. Accepted for publication in: Nanoscale DOI 10.1039/C7NR04480A

Lohan SB, Saeidpour S, Solik A, Schanzer S, Richter H, Dong P, Darvin ME, Bodmeier R, Patzelt A, Zoubari G, Unbehauen M, Haag R, Lademann J, Teutloff C, Bittl R, Meinke MC 2017. Investigation of the cutaneous penetration behavior of dexamethasone loaded to nano-sized lipid particles by EPR spectroscopy, and confocal Raman and Laser scanning microscopy. Accepted for publication in  Eur J Pharm Biopharm, in press, DOI 10.1016/j.ejpb.2016.12.018

Saeidpour S, Lohan SB, Solik A, Paul V, Bodmeier R, Zoubari G, Unbehauen M, Haag R, Bittl R, Meinke MC, Teutloff C 2017. Drug distribution in nanostructured lipid particles. Eur J Pharm Biopharm, in press, DOI 10.1016/j.ejpb.2016.10.008 (Epub ahead of print)

Saeidpour S, Lohan SB, Anske M, Unbehauen M, Fleige E, Haag R, Meinke MC, Bittl R, Teutloff C 2016. Localization of dexamethasone within dendritic core-multishell (CMS) nanoparticles and skin penetration properties studied by multi-frequency electron paramagnetic resonance spectroscopy (EPR). Eur J Pharm Biopharm, in press, DOI 10.1016/j.ejpb.2016.10.001 (Epub ahead of print)

Lohan SB, Icken N, Teutloff C, Saeidpour S, Bittl R, Lademann J, Fleige E, Haag R, Haag SF, Meinke MC 2016. Investigation of cutaneous penetration properties of stearic acid loaded to dendritic core-mulit-shell (CMS) nanocarriers. Int J Pharm 501:271-277 DOI 10.1016/j.ijpharm.2016.02.004